The SELECT trial and subsequent renal subgroup analyses suggested that, in populations with both obesity and pre-existing cardiovascular disease, semaglutide not only reduced the risk of cardiovascular events but also slowed the decline of the estimated glomerular filtration rate (eGFR) ( As indications have expanded from diabetes to obesity, GLP-1RAs have increasingly entered routine care for women of reproductive age, including those with PCOS, in whom obesity and insulin resistance are highly prevalent ( 1.4 Rationalizing fertility-centered review of GLP-1RAs in PCOS: bridging metabolic-reproductive divide 1.4.1 Clinical paradox: tension between metabolic optimization and reproductive urgency While GLP-1RAs have been established as a first-line intervention for managing metabolic comorbidities in PCOS, their potential teratogenic risks and the requirement for strict preconception washout periods present a formidable clinical dilemma for reproductive specialists
sperm count, which is definitely important
Form Health executives say patients lose an average of 15% of their body weight at twelve months
Third, check the pen label to confirm it is the correct medication and the correct dose
Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancers
Corinne to discuss a comprehensive, personalized approach to your weight loss goals
